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Abstract
Background: The Philippines has an extremely high rate of tuberculosis but little is known about M. tuberculosis
genotypes and transmission dynamics in this country. The aim of this study was to determine the proportion of
household contacts who develop active TB due to direct transmission from an index case in that household.
Methods: Mycobacterium tuberculosis isolates from household contacts of tuberculosis patients in the Philippines
were characterized using restriction-fragment-length polymorphism analysis, spoligotyping, and mycobacterial
interspersed repetitive units – variable number tandem repeats typing (12-loci) to determine their utility in
elucidating transmission in an area of high tuberculosis prevalence. Drug susceptibility patterns for these isolates
were also determined.
Results: Spoligotyping and MIRU-VNTR typing results matched in 10 (62.5%) of 16 index patient-household contact
pairs while IS6110 fingerprints matched in only six (37.5%) pairs. Only 3/16 (18.8%) index patient-household contact
pairs had identical drug susceptibility results.
Conclusions: Strain typing of M. tuberculosis isolates from household contacts in the Philippines indicates that
transmission of strains does not necessarily occur directly from the index patient living in close proximity in the
same household but rather that community-based transmission also frequently occurs. Accurate susceptibility
testing of all isolates is necessary to insure optimal care of both the index patients and any culture-positive
household contacts.
Background
Tuberculosis (TB) is a serious global health problem,
with the largest number of cases disproportionately oc-
curring in developing countries. The Philippines is one
of the countries hardest hit by the disease, with the se-
cond highest TB incidence in Asia [1]. We previously re-
ported a remarkably high prevalence of 12.8% for TB
disease and 65.6% for TB infection among household
contacts of tuberculosis patients in the Philippines [2].
The Philippines also bear a significant proportion of the
global multidrug resistant (MDR) TB burden [3,4]. Al-
though the Philippines have an extremely high rate of
TB, little is known about M tuberculosis genotype and
transmission dynamics in this country. The aim of this
study was to determine the proportion of household
contacts who develop active TB due to direct transmis-
sion from an index case in that household.
Molecular genotyping has advanced the understanding
of M tuberculosis transmission and is helpful in iden-
tifying transmission links in a community. Restriction
fragment-length polymorphism (RFLP) analysis of the
insertion sequence 6110 (IS6110) is often used for geno-
typing of M tuberculosis. However, molecular charac-
terization using RFLP method is laborious and requires
culture for several weeks to obtain large quantities of
genomic DNA. In addition, RFLP has poor discrimin-
atory power for isolates with low numbers of insertion
sites [5]. The development of PCR-based typing methods
has enabled rapid mycobacterial genotyping [6,7]. Spacer
oligonucleotide typing (spoligotyping) is a rapid PCR-
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based method that examines DNA polymorphisms at
the unique direct repeat (DR) region of M tuberculosis.
It is easier to perform and requires smaller amounts of
DNA than RFLP analysis but its discriminatory capacity
is inferior to RFLP. Spoligotyping is useful in discrimin-
ating strains with low IS6110 copy numbers and it can
be performed on nonviable organisms. Mycobacterial in-
terspersed repetitive units (MIRU) – variable number
tandem repeats (VNTR) is another PCR-based method
that is easily reproducible and does not require extensive
DNA purification. MIRU-VNTR [8] has become a major
method for rapid, high-resolution genotyping of M tu-
berculosis complex isolates. The method relies on PCR
amplification of multiple loci (12, 15 or 24 loci) using
primers specific for the flanking regions of each repeat
locus and on the determination of the sizes of the ampli-
cons, which reflect the numbers of the targeted MIRU-
VNTR copies [9]. Moreover, the results are expressed as
numerical codes and are therefore easy to compare and
exchange between laboratories [10].
Only a limited number of M tuberculosis isolates from
the Philippines have been genotyped [11,12]; no studies
have described the epidemiologic links among isolates.
The aims of this study were to characterize M tubercu-
losis isolated from TB patients in Philippine households
using three methods for genotyping, namely RFLP, spoli-
gotyping, and MIRU-VNTR, and to describe the trans-
mission and drug susceptibility patterns of these isolates.
Methods
Study isolates
Sputum for acid-fast bacilli (AFB) smear microscopy and
culture were collected from the index case (IC) and
household contact (HC) cases during a contact investi-
gation study on sputum smear-positive TB patients seen
at the Tropical Disease Foundation DOTS Clinic, Makati
Medical Center, Metro Manila between 2001 and 2003
[2,13]. Two hundred eighteen index cases aged ≥18 years
with sputum smear-positive TB, including 163 (74.8%)
with MDR-TB, were identified. Eight hundred ninety
seven of their household contacts were evaluated for TB
with tuberculin skin test, chest x-ray and sputum exa-
mination. One hundred thirteen (12.8%) household con-
tacts with TB were identified by positive chest x-rays
and/or positive sputum results; of these, 20 were sputum
culture-positive. A total of 29M tuberculosis paired iso-
lates were available from 13 index patients and 16
household contacts. Patients were between the ages of
10 and 60 (mean, 31) years; eight were females, 21 were
males.
All sputum specimens were first processed and cul-
tured on Lowenstein-Jensen slants and strain identifica-
tion was performed in the Philippines using the nitrate
and niacin tests according to established protocols [14].
The identification of the isolates was confirmed in the
United States prior to genotyping studies using a nucleic
acid hybridization probe specific for M. tuberculosis
complex (GenProbe AccuProbe®, San Diego, CA). Anti-
microbial susceptibility testing was performed in the
Philippines and confirmed in the United States using
Clinical and Laboratory Standards Institute guidelines
[15] with the 1% indirect agar proportion method used
for all antimicrobial agents except pyrazinamide. Pyrazi-
namide was tested using the VersaTREK broth system
(TREK Diagnostics, Cleveland, OH). Isolates were ge-
notyped using RFLP IS6110 fingerprinting [5], spoli-
gotyping [6] and 12-loci MIRU-VNTR typing [16] as
previously described.
Ethics statement
The study was approved by the Institutional Review
Boards of Mayo Clinic Rochester and the Tropical Disease
Foundation - Makati Medical Center. Written informed
consent was obtained from all patients, adult household
contacts, and/or head of household.
Results
Genotyping
IS6110 fingerprinting, spoligotyping and 12-loci MIRU-
VNTR typing were done on 29M tuberculosis isolates
from 13 households in the Philippines (Table 1). One
household had three household contacts with TB; an-
other household had two contacts with TB. Altogether,
there were 16 paired IC-HC isolates. Genotyping found
23 IS6110 fingerprints, 9 spoligotypes, and 13 MIRU-
VNTR types.
Isolates had between 11 and 19 (median, 13) copies of
IS6110 by RFLP. By spoligotyping, two isolates from one
household (Table 1, IC9 and HC9) had the Beijing ge-
notype and 17 (58.6%) of isolates from nine house-
holds lacked eight spacers characteristic of the Manila
family [12].
Spoligotyping and MIRU-VNTR typing both matched
in 10 (62.5%) of 16 pairs while IS6110 fingerprints
matched in only six (37.5%) IC-HC pairs. All six pairs
with matching IS6110 fingerprints also matched by spo-
ligotypes and MIRU-VNTR types. Three paired isolates
matched by only one genotyping method, and the
remaining three pairs had genotypes that were different
by all three fingerprinting methods.
Drug susceptibility testing
Results of drug susceptibility testing are shown in
Table 2. Only four of the 29 (13.8%) isolates were fully
susceptible to all first line drugs; eight (27.6%) were re-
sistant to all first line drugs. Isoniazid (INH) resistance
was detected in 24/29 (82.8%) and 19/29 (65.5%) at
low (0.2 μg/ml) and high (1.0 μg/ml) concentrations,
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Table 1 IS6110 Restriction fragment length polymorphism (RFLP), spoligotyping, and mycobacterial interspersed repetitive unit variable numbers of tandem
repeat (MIRU-VNTR) typing patterns of Mycobacterium tuberculosis isolates from index case (IC) and household contact (HC) cases from the Philippines
Household/
index group RFLP Pattern Spoligotype pattern MIRU-VNTR Code Lineage/family Methods with matching paired IC-HC DST match?
1 Spacer # 43
IC1 5–13 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 244336223432 Manila
HC1 5–13 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 244336223432 Manila RFLP/Spoligo/MIRU No
IC2 10–14 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 254326223432 Manila
HC2 34–13 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 254326223432 Manila Spoligo/MIRU No
IC3 2–13 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ □□□ □□□ □□■ ■■■ ■■■ ■ 254326223432 ND
HC3 2–13 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ □□□ □□□ □□■ ■■■ ■■■ ■ 254326223432 ND RFLP/Spoligo/MIRU No
IC4 35–11 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 254326223422 Manila
HC4 3–12 ■■□ ■■■ ■■■ ■■■ ■□□ □■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 254326223432 ND None No
IC5 1–13 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 254326223332 Manila
HC5 1–13 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 254326223332 Manila RFLP/Spoligo/MIRU Yes
IC6 11–15 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 234326223432 Manila
HC6.1 4–16 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 234326223432 Manila Spoligo/MIRU (IC6/HC6.1) No
HC6.2 6–14 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 234326223432 Manila Spoligo/MIRU (IC6/HC6.2) No
HC6.3 7–13 □■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □□□ ■■■ ■■■ ■ 253326223432 ND None (IC6/HC6.3) No
IC7 19–12 ■■□ ■■■ ■□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□■ ■■■ ■ 254326223432 ND
HC7.1 20–13 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 254326223432 Manila MIRU (IC7/HC7.1) No
HC7.2 18–11 ■■□ ■■■ □■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □□■ □■■ ■■■ ■ 274326223432 ND None (IC7/HC7.1) No
IC8 12–15 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 234326223432 Manila
HC8 37–13 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 254326223432 Manila Spoligo No
IC9 14–19 □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □■■ ■■■ ■■■ ■ 223325173533 Beijing
HC9 14–19 □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □■■ ■■■ ■■■ ■ 223325173533 Beijing RFLP/Spoligo/MIRU Yes
IC10 27–12 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 254326223422 Manila
HC10 27–12 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 254326223422 Manila RFLP/Spoligo/MIRU Yes
IC11 25–15 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ □□□ □□□ □□□ □□□ □□□ □□□ □ 254326224332 ND
HC11 23–12 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 254326223432 ND MIRU No
IC12 32–11 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■■□ □□□ □□□ □□□ ■■□ □□□ ■■■ ■■■ ■ 224227163221 ND
HC12 28–13 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■■□ □□□ □□□ □□□ ■■□ □□□ ■■■ ■■■ ■ 224227163321 ND Spoligo/MIRU No
IC13 29–11 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 354326223422 Manila
HC13 29–11 ■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■ 354326223422 Manila RFLP/Spoligo/MIRU No
RFLP = restriction fragment length polymorphism; Spoligo = spligotyping; MIRU =multiple interspersed repeating units/variable number tandem repeats; ND = not determined; IC = index case; HC = household contact
patient, DST = drug susceptibility.



















respectively. Resistance to rifampin (RIF), ethambutol
(EMB) and pyrazinamide (PZA) occurred in 19/29
(65.5%), 14/29 (48.3%), and 9/28 (32.1%), respectively.
There were 19 (65.5%) MDR M tuberculosis isolates.
With second line drugs, resistance to streptomycin
(STR) at 2.0 μg/ml, streptomycin at 10 μg/ml, capreo-
mycin (CAP), and ethionamide (ETH) was detected in
16/29 (55.2%), 13/29 (44.8%), 3/29 (10.3%), and 6/29
(20.7%), respectively. Resistance to kanamycin (KAN),
amikacin (AMI), cycloserine (CYC) and para-aminosa-
licylic acid (PAS) was not detected. Because resistance
testing to fluoroquinolones was not performed, the num-
ber of extensively-drug resistant isolates is not known.
Comparing test results of paired IC-HC isolates, only
3/16 (18.8%) had identical drug susceptibility results. In
one household with four cases of TB (IC6), only two iso-
lates had the same susceptibility pattern. Both isolates
with the Beijing genotype were multidrug resistant,
Table 2 Drug susceptibilities of Mycobacterium tuberculosis isolates from index case (IC) and household contact (HC)
cases in the Philippines
First line drugsa Second line drugs
Household/
index contacts
INH RIF EMB PZA STR CAP KAN AMI ETH CYC PAS
0.2 1.0 1.0 7.5 300 2.0 10 10 6.0 6.0 10 60.0 8.0
IC1 R R R R R S S S S S S S S
HC1 R R S S S S S S S S S S S
IC2 R R R R R R R S S S S S S
HC2 R R R S S R R S S S S S S
IC3 R S R S S R R S S S S S S
HC3 R R R S S S S S S S S S S
IC4 R R R S N/Ab R S S S S R S S
HC4 R R S S S R S S S S S S S
IC5 R R R R R R R S S S S S S
HC5 R R R R R R R S S S S S S
IC6 R R R R R R R S S S R S S
HC6.1 R R R R S R R S S S R S S
HC6.2 R R R R S R R S S S R S S
HC6.3 S S S S S S S S S S S S S
IC7 R S R R S R R S S S R S S
HC7.1 S S S S S S S S S S S S S
HC7.2 S S S S S S S S S S S S S
IC8 R S S S S S S S S S S S S
HC8 S S S S R S S S S S S S S
IC9 R R R R R R R S S S S S S
HC9 R R R R R R R S S S S S S
IC10 R S S S S S S S S S S S S
HC10 R S S S S S S S S S S S S
IC11 S S S S S S S S S S S S S
HC11 R R R S S S S R S S R S S
IC12 R R R R R R R R S S S S S
HC12 R R R R S R R R S S S S S
IC13 R R R R S R S S S S S S S
HC13 R R R R S S S S S S S S S
Susceptibilities are reported in μg/mL.
Abbreviations: INH – isoniazid, RIF – rifampin, EMB – ethambutol, PZA – pyrazinamide, STR – streptomycin, CAP – capreomycin, KAN – kanamycin, AMI – amikacin,
ETH – ethionamide, CYC – cycloserine, PAS – para-aminosalicylic acid; R – resistant, S – susceptible.
aWith the exception of PZA, susceptibility for all drugs was performed by the 1% indirect agar proportion method. PZA susceptibility was performed on the
VersaTREK (TREK Diagnostics, Cleveland, OH).
bIsolate unable to grow in test medium for PZA susceptibility testing.
Sia et al. BMC Infectious Diseases 2013, 13:571 Page 4 of 8
http://www.biomedcentral.com/1471-2334/13/571
whereas 11 of 17 (64.7%) isolates with the Manila geno-
type were multidrug resistant.
Discussion
DNA fingerprinting of M tuberculosis has transformed
our understanding of the transmission of TB and pro-
vides a tool for the identification of transmission pat-
terns. We sought to better understand TB transmission
in the Philippines, which has a high TB and MDR TB
burden, by molecular characterization of M tuberculosis
isolates from household contacts of TB cases. Using
three genotyping methods, our results show that based
on the highest level of discrimination by IS6110 finger-
printing, approximately two-thirds (10/16, 62.5%) of TB
in household contacts may have been acquired from a
source outside of the household. A number of studies
have elucidated that household contacts of TB patients
have a higher risk of being infected [17-20]. In high TB
prevalence setting, there are multiple sources of infec-
tion and numerous opportunities for TB transmission as
a result of social mixing [21].
In Capetown, South Africa, where TB is highly en-
demic, RFLP analysis of 313 isolates from 129 house-
holds showed matching fingerprints in only 46%; the
authors estimated that proportion of TB transmission
occurring in household is only 19% [22]. Metro Manila
is the largest city in the Philippines, with a population of
over 11 million people, and a large number of urban
poor settlements where TB is a substantial problem [23].
We analyzed M tuberculosis isolates that were collected
from index and household contact TB cases in Metro
Manila. IS6110 genotypes from household contacts
matched those of index cases in six of 16 (37.5%). In the
two households with more than two TB cases (IC6 and
IC7), none of the isolates from the same household
matched in IS6110 fingerprint. The fact that individuals
with TB from the same household are infected with dif-
ferent strains of M tuberculosis suggests that the infec-
tion was acquired from outside the household, and most
likely reflects the TB burden in the community.
Very few studies have been done to molecularly cha-
racterize M tuberculosis isolates from the Philippines.
Analysis of 40 randomly collected isolates from the
Philippines revealed that 38 of isolates had 80% or
greater similarity, but non-identical, IS6110 fingerprints;
these isolates has been given the designation as the
Manila family [12]. In another study, 33 of 34 (97.0%)
isolates from the Philippines also collected at random,
showed similar but distinct IS6110 fingerprints [11].
These isolates had more than eight copies of IS6110,
most having 13 copies. Our findings corroborate the
presence of different strains of M tuberculosis with 11
or greater copies of IS6110 circulating in the
community.
Spoligotyping of 48M tuberculosis isolates from
Manila showed patterns that were highly similar; 41/48
(85.4%) had identical patterns lacking hybridization to
eight spacers [12]. These isolates have been classified as
the Manila family. In our study on 29 isolates, 17 (58.6%)
lacked hybridization to these spacers.
In The Gambia, spoligotyping on nine paired index-
household cases revealed six (66.6%) pairs to match and
three (33.3%) that were unmatched [24]. Our results
showed a similar rate of spoligotype matching in 11 of
16 (68.8%) pairs. In the Philippines where most isolates
of M tuberculosis have ≥8 copies of IS6110 [12], spoligo-
typing does not appear to be sufficiently discriminatory
as an epidemiologic tool. We detected the same num-
ber of matched isolates (11/16) with MIRU-VNTR as
spoligotyping.
IS6110 RFLP typing [25] has been replaced in some
settings with easier-to-perform, alternative PCR-based
strategies, such as spoligotyping and MIRU-VNTR. These
alternative typing methods, with classical epidemiological
investigations, are being internationally adopted as the
new reference method for TB molecular epidemiology
[26,27]. A recent population-based study indicated that
the use of MIRU-VNTR system as a first-line method in
combination with spoligotyping provides adequate dis-
crimination in most cases for large-scale, prospective
genotyping of M. tuberculosis in the United States [28].
However, IS6110 fingerprinting is still useful as an add-
itional method to type the clustered isolates in a number
of cases. The combination of these two PCR-based typing
methods may be useful in low TB prevalence settings [28],
but its utility in high TB prevalence settings has yet to be
clearly demonstrated. In our sample of 16 paired isolates
for example, the combination of spoligotyping and
MIRU-VNTR typing matched 10 pairs of isolates, whereas
IS6110 fingerprinting further discriminated the isolates
into only six matching pairs.
We tested a high number of MDR M tuberculosis iso-
lates; this was expected since we identified patients at a
referral center for treatment of MDR TB [29]. Compar-
ing fingerprint data with drug susceptibility results, only
three of the six (50.0%) pairs with identical genotypes
had matching drug susceptibility. There were no observ-
able patterns in terms of the matched isolates being
from a particular type of household relationship (eg., the
young child or the partner of an index case) or in the
length of time between diagnosis of the index patient
and the household contact(s) (Table 3). Since 10 of 13
index patients had MDR-TB, we were unable to deter-
mine whether MDR-TB patients were more likely to
transmit TB to a household contact than the non-MDR
index patients. These finding have implications in the
treatment of TB and highlight the importance of drug sus-
ceptibility testing; treatment of TB in household contacts
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cannot be inferred from drug susceptibility of M tubercu-
losis of index patients.
Our study has some limitations. We tested only a
small number of isolates, and samples were collected
from a TB referral center in one geographic area in the
Philippines. Our results may not reflect the predomin-
antly circulating strains of M tuberculosis in the general
population. Lately, MIRU-VNTR typing of 15 or 24 loci
has been applied to molecular typing of M tuberculosis;
we may have found more genetic diversity in our sam-
ples with 24-loci method than with the 12-loci method
used in this study. Nonetheless, our data demonstrate
that there is significant genotype and drug susceptibi-
lity diversity within households with multiple cases of
tuberculosis.
Conclusions
Patients in high TB burden regions are exposed to TB
outside the home, and therefore may be infected by
source patients outside the home. Genotyping of M tu-
berculosis from the Philippines will aid in understanding
the epidemiology of TB of this country, which can lead
to improved strategies to reduce TB prevalence in the
country.
Our results augment the findings from other studies
that in highly prevalent areas, TB transmission is as
likely to occur in the community as it is within the
household. Furthermore, our data highlights the import-
ance of drug susceptibility testing particularly for house-
hold contacts of MDR TB patients to ensure that they
receive the appropriate drugs to which their isolates are













IC1 2001 41 F
HC1 2001 0 22 F child N Y
IC2 2001 28 M
HC2 2001 0 18 M sibling N N
IC3 2001 52 M
HC3 NA NA 22 F child N Y
IC4 2001 38 M
HC4 2001 0 10 M child N N
IC5 2001 42 M
HC5 2001 0 22 M child Y Y
IC6 2002 17 M
HC6.1 2002 0 20 M sibling N N
HC6.2 2002 0 29 M sibling N N
HC6.3 2002 0 22 M sibling N N
IC7 2002 43 M
HC7.1 2002 0 33 F sibling N N
HC7.2 NA NA 41 M sibling N N
IC8 2001 28 F
HC8 2007 6 60 M parent N N
IC9 2001 19 M
HC9 2003 2 30 M sibling Y Y
IC10 2000 40 M
HC10 2003 3 40 F sibling Y Y
IC11 2003 NA M
HC11 2004 1 NA M NA N N
IC12 2003 30 F
HC12 2004 1 28 F sibling N N
IC13 2003 49 M
HC13 2008 5 32 M child N Y
DST = drug susceptibility testing, NA = not available, Y = yes, N = no.
aUsing all 3 methods (spoligotyping, MIRU-VNTR and RLFP).
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susceptible. Our results have significant implications to
TB control in the Philippines. Strain typing of TB pro-
vides valuable information on the number and type of
strains circulating in a community; more importantly, it
provides information on the transmission, which informs
prevention and control. Further studies on a larger num-
ber of isolates are needed to properly elucidate the epi-
demiology and transmission of TB in this country.
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